Literature DB >> 21567283

Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction.

Daniel D Anselm1, Anjali H Anselm, Jennifer Renaud, Harold L Atkins, Robert de Kemp, Ian G Burwash, Kathryn A Williams, Ann Guo, Cathy Kelly, Jean Dasilva, Rob S B Beanlands, Christopher A Glover.   

Abstract

BACKGROUND: Reperfused myocardium post-acute myocardial infarction (AMI) may have altered metabolism with implications for therapy response and function recovery. We explored glucose utilization and the "reverse mismatch" (RMM) pattern (decreased F-18-fluorodeoxyglucose (FDG) uptake relative to perfusion) in patients who underwent mechanical reperfusion with percutaneous coronary intervention (PCI) for AMI. METHODS AND
RESULTS: Thirty-one patients with anterior wall AMI treated with acute reperfusion, with left ventricular ejection fraction ≤45%, underwent rest rubidium-82 (Rb-82) and FDG PET 2-10 days post-AMI. Resting echocardiograms were used to assess wall motion abnormalities. Significant RMM occurred in 15 (48%) patients and was associated with a shorter time to PCI of 2.9 hours (2.2, 13.3 hours) compared to patients without significant RMM: 11.4 hours (3.9, 22.4 hours) (P = .03). Within the peri-infarct regions, segments with significant RMM were more likely to have wall motion abnormalities (OR = 2.3 (1.1, 4.7), P = .02) compared to segments without significant RMM.
CONCLUSIONS: RMM is a common pattern on perfusion/FDG PET during the sub-acute phase following reperfusion of AMI and is associated with shorter times to PCI. Within the peri-infarct region, RMM occurs frequently and is more often associated with wall motion abnormalities than segments without RMM. Whether this represents a myocardial metabolic shift during the sub-acute phase of recovery warrants further study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567283     DOI: 10.1007/s12350-011-9389-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  46 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction.

Authors:  R J Gropler; B A Siegel; K Sampathkumaran; J E Pérez; B E Sobel; S R Bergmann; E M Geltman
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

3.  Reverse perfusion-metabolism mismatch predicts good prognosis in patients undergoing cardiac resynchronization therapy: a pilot study.

Authors:  Noriko Inoue; Nobukazu Takahashi; Toshiyuki Ishikawa; Shinichi Sumita; Tsukasa Kobayashi; Kohei Matsushita; Katsumi Matsumoto; Minoru Taima; Miei Shimura; Kazuaki Uchino; Kazuo Kimura; Tomio Inoue; Satoshi Umemura
Journal:  Circ J       Date:  2007-01       Impact factor: 2.993

4.  Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses.

Authors:  P Zanco; A Desideri; G Mobilia; S Cargnel; E Milan; L Celegon; R Buchberger; G Ferlin
Journal:  J Nucl Med       Date:  2000-06       Impact factor: 10.057

5.  CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary.

Authors:  R S B Beanlands; B J W Chow; A Dick; M G Friedrich; K Y Gulenchyn; M Kiess; H Leong-Poi; R M Miller; G Nichol; M Freeman; P Bogaty; G Honos; G Hudon; G Wisenberg; J Van Berkom; K Williams; K Yoshinaga; J Graham
Journal:  Can J Cardiol       Date:  2007-02       Impact factor: 5.223

6.  Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial.

Authors:  Dietlind Zohlnhöfer; Adnan Kastrati; Albert Schömig
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2007-02

Review 7.  Assessment of myocardial viability in patients with heart failure.

Authors:  Arend F L Schinkel; Don Poldermans; Abdou Elhendy; Jeroen J Bax
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

8.  Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.

Authors:  Rob S B Beanlands; Terrence D Ruddy; Robert A deKemp; Robert M Iwanochko; Geoffrey Coates; Michael Freeman; Claude Nahmias; Paul Hendry; Robert J Burns; Andre Lamy; Lynda Mickleborough; William Kostuk; Ernest Fallen; Graham Nichol
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

9.  Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model.

Authors:  M Schwaiger; H R Schelbert; D Ellison; H Hansen; L Yeatman; J Vinten-Johansen; C Selin; J Barrio; M E Phelps
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

10.  Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease.

Authors:  P Perrone-Filardi; S L Bacharach; V Dilsizian; J A Marin-Neto; S Maurea; J A Arrighi; R O Bonow
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

View more
  7 in total

1.  SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response.

Authors:  Michel Lalonde; David Birnie; Terrence D Ruddy; Robert A deKemp; Rob S B Beanlands; Richard Wassenaar; R Glenn Wells
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-09       Impact factor: 2.357

2.  Is having a sweetheart enough to survive?

Authors:  Samia Massalha; Riemer H J A Slart
Journal:  J Nucl Cardiol       Date:  2018-09-06       Impact factor: 5.952

3.  Microvascular function, is there a link to myocardial viability: Is this another piece to the puzzle?

Authors:  Fernanda Erthal; Natasha Aleksova; Aun Yeong Chong; Robert A de Kemp; Rob S B Beanlands
Journal:  J Nucl Cardiol       Date:  2016-07-05       Impact factor: 5.952

4.  Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction.

Authors:  Yoshitomo Fukuoka; Akira Nakano; Hiroyasu Uzui; Naoki Amaya; Kentaro Ishida; Kenichiro Arakawa; Takashi Kudo; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee; Hiroshi Tada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-27       Impact factor: 9.236

Review 5.  Acquisition, Processing, and Interpretation of PET 18F-FDG Viability and Inflammation Studies.

Authors:  Emel Celiker-Guler; Terrence D Ruddy; R Glenn Wells
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

6.  Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.

Authors:  Kuan-Yin Ko; Shan-Ying Wang; Ruoh-Fang Yen; Yu-Chien Shiau; Jung-Cheng Hsu; Hao-Yuan Tsai; Chien-Lin Lee; Kuan-Ming Chiu; Yen-Wen Wu
Journal:  J Nucl Cardiol       Date:  2018-08-14       Impact factor: 5.952

7.  Status of F-18 fluorodeoxyglucose uptake in normal and hibernating myocardium after glucose and insulin loading.

Authors:  Ismet Sarikaya; A H Elgazzar; M A Alfeeli; P N Sharma; A Sarikaya
Journal:  J Saudi Heart Assoc       Date:  2017-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.